Daewoong pharmaceutical

069620.KO

101.70 USD

-0.79

-0.77%

Overview

Last close

101.70 usd

Market cap

1.17B usd

52 week high

123.18 usd

52 week low

72.15 usd

Target price

155.61 usd

Valuation

P/E

N/A

Forward P/E

N/A

Price/Sales

1.0808

Price/Book Value

1.9577

Enterprise Value

1.60B usd

EV/Revenue

1.4765

EV/EBITDA

14.9119

Key financials

Revenue TTM

1.08B usd

Gross Profit TTM

558.32M usd

EBITDA TTM

159.39M usd

Earnings per Share

N/A usd

Dividend

0.44 usd

Total assets

1.56B usd

Net debt

422.10M usd

About

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.